Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death

被引:94
|
作者
Aneja, Ritu
Vanyapandu, Surya N.
Lopus, Manu
Viswesarappa, Vijaya G.
Dhiman, Neerupma
Verma, Akhilesh
Chandra, Ramesh
Panda, Dulal
Joshi, Harish C.
机构
[1] Emory Univ, Sch Med, Dept Cell Biol, Lab Drug Discovery & Res, Atlanta, GA 30322 USA
[2] Indian Inst Technol, Sch Biosci & Bioengn, Bombay, Maharashtra, India
[3] Univ Delhi, BR Ambedkar Ctr Biomed Res, Delhi 110007, India
关键词
cell cycle; mitotic arrest; anticancer; tubulin-binding;
D O I
10.1016/j.bcp.2006.05.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have previously identified the naturally occurring non-toxic antitussive phthalideiso-quinoline alkaloid, noscapine as a tubulin-binding agent that arrests mitosis and induces apoptosis. Here we present high-yield efficient synthetic methods and an evaluation of anticancer activity of halogenated noscapine analogs. our results show that all analogs display higher tubulin-binding activity than noscapine and inhibit proliferation of human cancer cells (MCF-7, MDA-MB-231 and CEM). Surprisingly, the bromo-analog is similar to 40-fold more potent than noscapine in inhibiting cellular proliferation of MCF-7 cells. The ability of these analogs to inhibit cellular proliferation is mediated by cell cycle arrest at the G(2)/M phase, in that all analogs except 9-iodonoscapine, caused selective mitotic arrest with a higher efficiency than noscapine followed by apoptotic cell death as shown by immunofluorescence and quantitative FACS analyses. Furthermore, our results reveal the appearance of numerous fragmented nuclei as evidenced by DAPI staining. Thus, our data indicate a great potential of these compounds for studying microtubule-mediated processes and as chemotherapeutic agents for the management of human cancers. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:415 / 426
页数:12
相关论文
共 50 条
  • [1] Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death (vol 72, pg 415, 2006)
    Aneja, Ritu
    Vanyapandu, Surya N.
    Lopus, Manu
    Viswesarappa, Vijaya G.
    Dhiman, Neerupma
    Verma, Akhilesh
    Chandra, Ramesh
    Panda, Dulal
    Joshi, Harish C.
    BIOCHEMICAL PHARMACOLOGY, 2008, 75 (06) : 1439 - 1440
  • [2] Synthesis of potent microtubule-interfering halogenated noscapine analogs that inhibit cellular proliferation and perturb mitosis
    Aneja, Ritu
    Vangapandu, Suryanarayana
    Lopus, Manu
    Panda, Dulal
    Joshi, Harish C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [3] Noscapine derivatives as potent microtubule-interfering agents that perturb mitosis and induce apoptosis
    Zhou, J
    Gupta, K
    Aggarwal, S
    Aneja, R
    Chandra, R
    Panda, D
    Joshi, HC
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 464A - 464A
  • [4] Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation
    Zhou, J
    Gupta, K
    Aggarwal, S
    Aneja, R
    Chandra, R
    Panda, D
    Joshi, HC
    MOLECULAR PHARMACOLOGY, 2003, 63 (04) : 799 - 807
  • [5] Novel third-generation water-soluble noscapine analogs as superior microtubule-interfering agents with enhanced antiproliferative activity
    Henary, Maged
    Narayana, Lakshminarayana
    Ahad, Shazia
    Gundala, Sushma R.
    Mukkavilli, Rao
    Sharma, Vibhuti
    Owens, Eric A.
    Yadav, Yogesh
    Nagaraju, Mulpuri
    Hamelberg, Donald
    Tandon, Vibha
    Panda, Dulal
    Aneja, Ritu
    BIOCHEMICAL PHARMACOLOGY, 2014, 92 (02) : 192 - 205
  • [6] The new microtubule-interfering compound MPI-0441138 acts as radiosensitizing agent in cancer cells in vitro
    Skvortsova, I
    Skvortsov, S
    Popper, BA
    Saurer, M
    Pleiman, C
    Lukas, P
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S48 - S48
  • [7] Differential sensitivity of BRCA1-mutated HCC1937 human breast cancer cells to microtubule-interfering agents
    Tassone, P
    Blotta, S
    Palmieri, C
    Masciari, S
    Quaresima, B
    Montagna, M
    D'Andrea, E
    Eramo, OP
    Migale, L
    Costanzo, F
    Tagliaferri, P
    Venuta, S
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (05) : 1257 - 1263
  • [8] Gene expression profiling of exposure to TZT-1027, a novel microtubule-interfering agent, in non-small cell lung cancer PC-14 cells and astrocytes
    Natsume, T
    Nakamura, T
    Koh, Y
    Kobayashi, M
    Saijo, N
    Nishio, K
    INVESTIGATIONAL NEW DRUGS, 2001, 19 (04) : 293 - 302
  • [9] Gene Expression Profiling of Exposure to TZT-1027, a Novel Microtubule-Interfering Agent, in Non-Small Cell Lung Cancer PC-14 Cells and Astrocytes
    Tsugitaka Natsume
    Takashi Nakamura
    Yasuhiro Koh
    Motohiro Kobayashi
    Nagahiro Saijo
    Kazuto Nishio
    Investigational New Drugs, 2001, 19 : 293 - 301
  • [10] EM012, a microtubule-interfering agent, inhibits the progression of multidrug-resistant human ovarian cancer both in cultured cells and in athymic nude mice
    Jun Zhou
    Min Liu
    Roopa Luthra
    Jeremy Jones
    Ritu Aneja
    Ramesh Chandra
    Rajeshwar R. Tekmal
    Harish C. Joshi
    Cancer Chemotherapy and Pharmacology, 2005, 55 : 461 - 465